LEMONIS MARCUS 4
4 · BED BATH & BEYOND, INC. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Bed Bath & Beyond (BBBY) CEO Marcus Lemonis Receives Performance Award
What Happened
Marcus Lemonis, Executive Chairman & CEO (and director) of Bed Bath & Beyond, was credited with 424,300 performance shares on Feb 4, 2026 after the compensation committee determined those shares were earned for fiscal 2025. The filing reports the performance-share award as a derivative grant (424,300 shares @ $0.00; reported value $424). The report also records a prior pro‑rata distribution of 45,615 warrants dated Oct 7, 2025 (reported value $46).
Key Details
- Transaction dates: Feb 4, 2026 (performance shares); Oct 7, 2025 (warrant distribution). Filing date: Feb 6, 2026. Filing appears timely.
- Reported amounts: 424,300 performance shares (derivative, reported $424); 45,615 warrants (reported $46).
- Exercise/strike: Each warrant (from Oct 7, 2025 distribution) entitles holder to buy one share at $15.50 per warrant.
- Shares owned after transaction: not disclosed in this Form 4 filing.
- Footnotes: F1 — performance shares are contingent rights to receive common stock and will vest in three equal installments (Mar 10, 2026; Mar 10, 2027; Mar 10, 2028) subject to continued service and satisfaction of performance criteria. F2 — warrants were a pro‑rata distribution exempt from immediate Section 16 reporting.
Context
These are compensation-related derivative awards, not open‑market purchases or sales. The performance shares are contingent and will only convert to stock if performance and service conditions are met; the warrants give the right to buy stock at $15.50. Such awards reflect compensation outcomes and do not by themselves indicate an immediate insider purchase or sale.
Insider Transaction Report
- Award
Performance Shares
[F1]2026-02-04$0.00/sh+424,300$424→ 424,300 total→ Common Stock (424,300 underlying) - Award
Common Stock Warrants
[F2]2025-10-07$0.00/sh+45,615$46→ 45,616 totalExercise: $15.50From: 2025-12-03Exp: 2026-10-07→ Common Stock (45,615 underlying)
Footnotes (2)
- [F1]Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, the earned performance shares will vest based on continued service through the applicable vesting date specified above.
- [F2]Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of the Registrant's common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.